Brigham & Women’s Hospital
Department of Medicine
Division of Pharmacoepidemiology & Pharmacoeconomics
1620 Tremont Street, Suite 3030,
Boston, MA 02120
krothman@rics.bwh.harvard.edu
Phone: 617-278-0930 | Fax: 617-232-8602
Kenneth Rothman, DrPH, MPH, is a Visiting Professor of Medicine at the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women’s Hospital and Harvard Medical School. Dr. Rothman has conducted epidemiologic research on the epidemiology of cancer, cardiovascular disease, birth defects, environmental epidemiology, and methodologic, conceptual and ethical issues in epidemiology. His research has included work on the teratogenicity of vitamin A, the health effects of cellular telephone use, and potential environmental risk factors for cancer.
Dr. Rothman is the author of two widely used textbooks of epidemiologic methods, Modern Epidemiology, now in its third edition, and Epidemiology, An Introduction. He also was the founding editor of Epidemiology, a prominent public health journal.
Selected Publications | Current PubMed Search Results
- Rothman KJ, Michels KB. The Declaration of Helsinki should be strengthened. BMJ 2000; 321:442-445.
- Rothman KJ. Health risks of cellular telephones. Lancet 2000; 356:1837-1840.
- Rothman KJ, Ray W. Should cases with a ‘known’ cause of
their disease be excluded from study? Pharmacoepidemiol Drug Safety 2002; 11:11-14. - Rothman KJ, Wentworth CE. Mortality of cystic fibrosis patients receiving tobramycin solution for inhalation. Epidemiology 2003; 14:55-59.
- Rothman KJ, Funch DP, Alfredson T, Brady J, Dreyer NA. Randomized field trial of vaginal douching, pelvic inflammatory disease, and pregnancy. Epidemiology 2003; 14;340-348.
- Rothman KJ, Mahon BE. Confounding and effect-measure modification in the evaluation of immunogenic agents. Eur J Epidemiol 2004; 19:205-207.
- Rothman KJ. A potential bias in safety evaluation during open-label extensions of randomized clinical trials. Pharmacoepidemiol Drug Safety 2004; 13:295-298.
- Rothman KJ, Lanes S, Sacks ST. The reporting odds ratio and its advantages over the proportional reporting ratio. Pharmacoepidemiol Drug Safety 2004; 13:519-523.
- Rothman KJ, Greenland S. Causation and causal inference in epidemiology. Am J Public Health 2005;95:S144-50.
- Rothman KJ. Real world data. Value in Health 2007;10:322-323.